Drug Profile
Research programme: CNS therapeutics - Eli Lilly and Company/NeuroSearch
Alternative Names: CNS therapeutics - Eli Lilly and Company/NsDiscoveryLatest Information Update: 04 Dec 2013
Price :
$50
*
At a glance
- Originator NeuroSearch
- Class
- Mechanism of Action Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued CNS disorders